Ryan Cohlhepp serves as Executive at Bicara Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Ryan Cohlhepp has executed 16 insider transactions totaling $1.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 26, 2025 involved exercising options for 25,000 shares valued at $111.0K.
Ryan Cohlhepp currently holds 214,141 shares of Bicara Therapeutics Inc. (BCAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ryan Cohlhepp has been a net seller of BCAX stock. They have purchased $0 and sold $1.6M worth of shares.
Ryan Cohlhepp's most recent insider trade was on Dec 26, 2025, when they sold 25,000 shares at $4.44 per share.
Get notified when new Form 4 filings are submitted
| 8,000 |
| $3.79 |
| Discretionary |
| Dec 15, 2025 | BCAX | $149.4K | Sale | 8,000 | $18.68 | Discretionary |
| Dec 15, 2025 | BCAX | $84.1K | Sale | 4,500 | $18.68 | Discretionary |
| Nov 21, 2025 | BCAX | $144.4K | Sale | 8,000 | $18.05 | Discretionary |
| Nov 21, 2025 | BCAX | $81.2K | Sale | 4,500 | $18.05 | Discretionary |
| Nov 21, 2025 | BCAX | $30.3K | Option Exercise | 8,000 | $3.79 | Discretionary |
| Oct 15, 2025 | BCAX | $30.3K | Option Exercise | 8,000 | $3.79 | Discretionary |
| Oct 15, 2025 | BCAX | $81.7K | Sale | 4,500 | $18.16 | Discretionary |
| Oct 15, 2025 | BCAX | $145.3K | Sale | 8,000 | $18.16 | Discretionary |
| Oct 7, 2025 | BCAX | $30.3K | Option Exercise | 8,000 | $3.79 | Discretionary |
| Oct 7, 2025 | BCAX | $144.5K | Sale | 8,000 | $18.06 | Discretionary |
| Oct 7, 2025 | BCAX | $52.4K | Sale | 2,900 | $18.06 | Discretionary |
| Oct 6, 2025 | BCAX | $91.0K | Option Exercise | 24,000 | $3.79 | Discretionary |
| Oct 6, 2025 | BCAX | $433.4K | Sale | 24,000 | $18.06 | Discretionary |
| Oct 6, 2025 | BCAX | $281.7K | Sale | 15,600 | $18.06 | Discretionary |